AnaptysBio Inc (ANAB)

14.50 -0.50 (-3.33%) USD  |  NASDAQ  |  Dec 20, 16:00
14.54 +0.04 (+0.31%) After-Hours: 20:00
More

AnaptysBio Max Drawdown (5Y): 90.03% for Nov. 30, 2024

Max Drawdown (5Y) Chart

View Max Drawdown (5Y) for ANAB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Max Drawdown (5Y) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Max Drawdown Definition

View Max Drawdown Definition
Start Trial

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Eli Lilly and Co 24.12%
SIGA Technologies Inc 82.20%
Candel Therapeutics Inc --
NovaBay Pharmaceuticals Inc 99.98%
Palatin Technologies Inc 97.38%

Max Drawdown (5Y) Related Metrics

Alpha (5Y) 12.17
Beta (5Y) -0.1113
Annualized Standard Deviation of Monthly Returns (5Y Lookback) 64.47%
Historical Sharpe Ratio (5Y) 0.1658
Historical Sortino (5Y) 0.3652
Monthly Value at Risk (VaR) 5% (5Y Lookback) 20.56%